ID   P30/OHK
AC   CVCL_1631
SY   P30-OHK; P30 OHK; P30OHK; P30/Ohkubo; P30/OHKUBO; P30-OHKUBO; P30/0HK
DR   CLO; CLO_0051011
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN01821712
DR   BioSample; SAMN03471069
DR   CCLE; P30OHK_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR   Cell_Model_Passport; SIDM00364
DR   ChEMBL-Cells; CHEMBL3308275
DR   ChEMBL-Targets; CHEMBL2366165
DR   Cosmic; 909252
DR   Cosmic; 919141
DR   Cosmic; 998703
DR   Cosmic; 1037718
DR   Cosmic-CLP; 909252
DR   DSMZ; ACC-727
DR   GDSC; 909252
DR   GEO; GSM827254
DR   GEO; GSM1670327
DR   JCRB; JCRB0094
DR   LINCS_LDP; LCL-1038
DR   RCB; RCB1938
DR   TKG; TKG 0463
DR   Wikidata; Q54937245
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=6983990;
RX   PubMed=9680106;
RX   PubMed=20215515;
RX   PubMed=27397505;
CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC   Part of: COSMIC cell lines project.
CC   Doubling time: ~30 hours (PubMed=6983990); ~30 hours (DSMZ).
CC   Microsatellite instability: Instable (MSI-high) (Sanger).
CC   Omics: Deep exome analysis.
CC   Omics: DNA methylation analysis.
CC   Omics: SNP array analysis.
CC   Omics: Transcriptome analysis.
CC   Derived from sampling site: Bone marrow.
ST   Source(s): Cosmic-CLP; DSMZ; JCRB; RCB; TKG
ST   Amelogenin: X
ST   CSF1PO: 9,11
ST   D13S317: 10
ST   D16S539: 9
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   TH01: 9
ST   TPOX: 10,11
ST   vWA: 14,21
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens
SX   Female
AG   11Y
CA   Cancer cell line
//
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RA   Drexler H.G.;
RT   "The leukemia-lymphoma cell line factsbook.";
RL   (In) ISBN 9780122219702; pp.1-733; Academic Press; London (2001).
//
RX   PubMed=6983990;
RA   Hirose M., Minato K., Tobinai K., Ohira M., Ise T., Watanabe S.,
RA   Shimoyama M., Taniwaki M., Abe T.;
RT   "A novel pre-T cell line derived from acute lymphoblastic leukemia.";
RL   Gann 73:600-605(1982).
//
RX   PubMed=9680106; DOI=10.1016/S0145-2126(98)00050-2;
RA   Matsuo Y., Drexler H.G.;
RT   "Establishment and characterization of human B cell precursor-leukemia
RT   cell lines.";
RL   Leuk. Res. 22:567-579(1998).
//
RX   PubMed=20215515; DOI=10.1158/0008-5472.CAN-09-3458;
RA   Rothenberg S.M., Mohapatra G., Rivera M.N., Winokur D., Greninger P.,
RA   Nitta M., Sadow P.M., Sooriyakumar G., Brannigan B.W., Ulman M.J.,
RA   Perera R.M., Wang R., Tam A., Ma X.-J., Erlander M., Sgroi D.C.,
RA   Rocco J.W., Lingen M.W., Cohen E.E.W., Louis D.N., Settleman J.,
RA   Haber D.A.;
RT   "A genome-wide screen for microdeletions reveals disruption of
RT   polarity complex genes in diverse human cancers.";
RL   Cancer Res. 70:2158-2164(2010).
//
RX   PubMed=27397505; DOI=10.1016/j.cell.2016.06.017;
RA   Iorio F., Knijnenburg T.A., Vis D.J., Bignell G.R., Menden M.P.,
RA   Schubert M., Aben N., Goncalves E., Barthorpe S., Lightfoot H.,
RA   Cokelaer T., Greninger P., van Dyk E., Chang H., de Silva H., Heyn H.,
RA   Deng X., Egan R.K., Liu Q., Mironenko T., Mitropoulos X.,
RA   Richardson L., Wang J., Zhang T., Moran S., Sayols S., Soleimani M.,
RA   Tamborero D., Lopez-Bigas N., Ross-Macdonald P., Esteller M.,
RA   Gray N.S., Haber D.A., Stratton M.R., Benes C.H., Wessels L.F.A.,
RA   Saez-Rodriguez J., McDermott U., Garnett M.J.;
RT   "A landscape of pharmacogenomic interactions in cancer.";
RL   Cell 166:740-754(2016).
//